High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma

Pediatrics

Volumn 118, Issue 2, 2006, Pages 644-650

  Schuh, Suzanne ^a   Dick, Paul T ^a   Stephens, Derek ^a   Hartley, Marlene ^a   Khaikin, Svetlana ^a   Rodrigues, Lisa ^a   Coates, Allan L ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Emergency department; Metered dose inhaler; Oral inhaled corticosteroids

Indexed keywords

FLUTICASONE; FLUTICASONE PROPIONATE PLUS SALMETEROL; IPRATROPIUM BROMIDE; PREDNISOLONE; SALBUTAMOL; SALMETEROL; ANDROSTANE DERIVATIVE; ANTIASTHMATIC AGENT;

ACUTE DISEASE; ADOLESCENT; ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; EMERGENCY WARD; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL DISCHARGE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; OUTCOME ASSESSMENT; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; TERTIARY HEALTH CARE; AIRWAY OBSTRUCTION; COMPARATIVE STUDY; DOSE RESPONSE; INHALATIONAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PRESCHOOL CHILD; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADOLESCENT; AIRWAY OBSTRUCTION; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; PREDNISOLONE; TREATMENT OUTCOME;

EID: 33748431112     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-2842     Document Type: Article

References (46)

1. Scarfone RJ, Fuchs SM, Nager AL, Shane SA. Controlled trial of oral prednisone in the emergency department treatment of children with acute asthma. Pediatrics. 1993;92:513-518
2. Harris J, Weinberger M, Nassif E, Smith G, Milavetz G, Stillerman A. Early intervention with short courses of prednisolone to prevent progression of asthma in ambulatory patients incompletely responsive to bronchodilators. J Pediatr. 1987;110:627-633
3. Shapiro GG, Furukawa CT, Pierson WE, Gardinier R, Bierman CW. Double-blind evaluation of methylprednisolone versus placebo for acute asthma episodes. Pediatrics. 1983;71:510-514
4. McFadden ER. Inhaled glucocorticoids and acute asthma: therapeutic breakthrough or nonspecific effect? Am J Respir Crit Care Med. 1998;157:677
5. Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol. 2000;142:931-936
6. Boulet LP. Perception of the role and potential side effects of inhaled corticosteroids among asthmatic patients. Chest. 1998;113:587-592
7. Crain EF, Weiss KB, Fagan MJ. Pediatric asthma care in US emergency departments. Current practice in the context of the National Institutes of Health guidelines. Arch Pediatr Adolesc Med. 1995;149:893-901
8. Toogood JH, Baskerville J, Jennings B, Lefcoe NM, Johansson SA. Bioequivalent doses of budesonide and prednisone in moderate and severe asthma. J Allergy Clin Immunol. 1989;84:688-700
9. Clinical Practice Guidelines. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. NIH Publication No. 97-4051. Bethesda, MD: National Institutes of Health, National Heart, Lung and Blood Institute; 1997
10. Foresi A, Morelli MC, Catena E. Low-dose budesonide with the addition of an increased dose during exacerbations is effective in long-term asthma control. On behalf of the Italian Study Group. Chest. 2000;117:440-446
11. Harding SM. The human pharmacology of fluticasone propionate. Respir Med. 1990;84(suppl A):25-29
12. Barnes NC, Marone G, Di Maria GU, Visser S, Utama I, Payne SL. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group. Eur Respir J. 1993;6:877-885
13. Fabbri L, Burge PS, Croonenborgh L, et al. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group. Thorax. 1993;48:817-823
14. Bootsma GP, Dekhuijzen PN, Festen J, Mulder PG, Swinkels LM, van Herwaarden CL. Fluticasone propionate does not influence bone metabolism in contrast to beclomethasone dipropionate. Am J Respir Crit Care Med. 1996;153:924-930
15. Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med. 1995;332:868-875
16. Adams RJ, Fuhlbrigge A, Finkelstein JA, et al. Impact of inhaled antiinflammatory therapy on hospitalization and emergency department visits for children with asthma. Pediatrics. 2001;107:706-711
17. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000;343:332-336
18. Szefler S, Weiss ST, Tonascia E. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med. 2000;343:1054-1063
19. Peden DB, Berger WE, Noonan MJ, et al. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma. J Allergy Clin Immunol. 1998;102:32-38
20. Schuh S, Reisman J, Alshehri M, et al. A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma. N Engl J Med. 2000;343:689-694
21. Nakanishi AK, Klasner AK, Rubin BK. A randomized controlled trial of inhaled flunisolide in the management of acute asthma in children. Chest. 2003;124:790-794
22. Scarfone RJ, Loiselle JM, Wiley JF, Decker JM, Henretig FM, Joffe MD. Nebulized dexamethasone versus oral prednisone in the emergency treatment of asthmatic children. Ann Emerg Med. 1995;26:480-486
23. Volovitz B, Bentur L, Finkelstein Y, et al. Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: a controlled comparative study with oral prednisolone. J Allergy Clin Immunol. 1998;102:605-609
24. Devidayal, Singhi S, Kumar L, Jayshree M. Efficacy of nebulized budesonide compared to oral prednisolone in acute bronchial asthma. Acta Paediatr. 1999;88:835-840
25. Manjra AI, Price J, Lenney W, Hughes S, Barnacle H. Efficacy of nebulized fluticasone propionate compared with oral prednisolone in children with an acute exacerbation of asthma. Respir Med. 2000;94:1206-1214
26. Nuhoglu Y, Bahceciler NN, Barlan IB, Mujdat Basaran M. The effectiveness of high-dose inhaled budesonide therapy in the treatment of acute asthma exacerbations in children. Ann Allergy Asthma Immunol. 2001;86:318-322
27. Edmonds ML, Camargo CA Jr, Pollack CV Jr, Rowe BH. The effectiveness of inhaled corticosteroids in the emergency department treatment of acute asthma: a meta-analysis. Ann Emerg Med. 2002;40:145-154
28. Rowe BH, Bota GW, Pollack CV, Emond SD, Camargo CA. Management of asthma among adults presenting to Canadian versus US emergency departments [abstract]. Ann Emerg Med. 1998;32:S1-S2
29. Thomas JA, Potter MW, Counselman FL, Smith DG. Emergency physician practice and steroid use in the management of acute exacerbations of asthma. Am J Emerg Med. 2001;19:465-468
30. Edmonds ML, Camargo CA, Pollack CV, Rowe BH. The effectiveness of inhaled corticosteroids in the emergency department treatment of acute asthma: a meta-analysis. Ann Emerg Med. 2002;40:145-154
31. Corey ML, Crozier DN, Levison H. Five to seven-year course of pulmonary function in Cystic Fibrosis. Am Rev Resp Dis. 1976;114:1085-1092
32. Ho SL, Kwong WT, O'Drowsky L, Coates AL. Evaluation of four breath-enhanced nebulizers for home use. J Aerosol Med. 2001;14:467-475
33. Newhouse MT, Dolovich MB. Control of asthma by aerosols. N Engl J Med. 1986;315:870-874
34. American Thoracic Society. Standardization of spirometry. 1994 update. American Thoracic Society. Am J Respir Crit Care Med. 1995;152:1107-1136
35. Subbarao P, Lebecque P, Corey M, Coates AL. Comparison of spirometric reference values. Pediatr Pulmonol. 2004;37:515-522
36. Diggle PJ, Liang K-Y, Zegerm SL. Analysis of longitudinal data. New York, NY: Oxford University Press; 1995
37. Little RC, Milliken GA, Walter W, Wolfinger RD. SAS system for mixed models: Cary, NC: SAS Institute; 1996
38. International Agency for Research of Cancer. Classical methods of analysis of grouped data. In: Statistical Methods in Cancer Research. Vol. 1. The Analysis of Case-Control Studies. Lyon, France: International Agency for Research of Cancer; 1980: IARC scientific publications no. 32
39. Ernst P, Suissa S. Measures of outcome. In: FitzGerald J, Ernst P, Boulet LP, O'Bryne P, eds. Evidence-Based Asthma Management. Hamilton, Ontario, Canada: BC Decker Inc; 2001
40. McFadden ERJ, Kiser R, DeGroot WJ. Acute bronchial asthma. Relations between clinical and physiologic manifestations. N Engl J Med. 1973;288:221-225
41. Dahl R, Martinati LC, Boner AL. Monitoring of bronchial asthma. Respir Med. 1997;91:581-586
42. Beaty TH, Newill CA, Cohen BH, Tockman MS, Bryant SH, Spurgeon HA. Effects of pulmonary function on mortality. J Chronic Dis. 1985;38:703-710
43. Kellie SE, Attfield MD, Hankinson JL, Castellan RM. Spirometry variability criteria - association with respiratory morbidity and mortality in a cohort of coal miners. Am J Epidemiol. 1987;125:437-444
44. Nair SJ, Daigle KL, DeCuir P, Lapin CD, Schramm CM. The influence of pulmonary function testing on the management of asthma in children. J Pediatr. 2005;147:797-801
45. Newnham DM, Lipworth BJ. Nebuliser performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebuliser delivery system ("Ventstream"). Thorax. 1994;49:762-770
46. Newman SP, Millar AB, Lennard-Jones TR. Improvement of pressurised aerosol deposition with Nebuhaler spacer device. Thorax. 1984;39:935-941